Cysteine engineered fibronectin type III domain binding molecules | Patent Number 11702475

US 11702475 B2
Application Number17303425
Publication NumberUS 20210301025 A1
Pendency2 years, 1 month, 21 days
Filled DateMay 28, 2021
Priority DateOct 14, 2013
Publication DateSep 30, 2021
Expiration DateOct 13, 2033
Inventor/ApplicantsShalom GOLDBERG
Shalom Goldberg
Karyn O'Neil
Steven Jacobs
Tricia Lin
ExaminesHOLLAND, PAUL J
Art Unit1656
Technology Center1600
Assignments
Janssen Biotech Inc.
Current
Janssen Biotech Inc.Johnson & Johnson
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.